Abstract
The primary goal in treating patients with breast cancer who have positive axillary lymph nodes is to achieve optimal tumor control while minimizing side effects that include breast cancer-related lymphedema (BCRL)
Funding Information
  • Japan Society for the Promotion of Science (JSPS) Kakenhi (JP 24K11748)

This publication has 31 references indexed in Scilit: